1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors

Coward, J, Lemech, C, Meniawy, T, Dupont, C D, Gonzalez, A M, Lim, M, Savitsky, D, Carini, M, Hu, S, Shebanova, O, Dow, E, Ortuzar, W, Buell, J S, Stein, R B, Youssoufian, H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy288.041
Date:
October, 2018
File:
PDF, 76 KB
2018
Conversion to is in progress
Conversion to is failed